“In a personal summary letter to the inventor about the Elanra MkII study and report, “The increase
in immune reactivity is convincing with a probability level of 0.001…further convincing evidence is
the concomitant drop in serotonin levels which have a link with the immune response…It is likely that
this enhancement will have an effect on reducing upper respiratory tract infections and benefit
allergy sufferers in the millions…we also found statistically significant but clinical benefits not yet
established on spore precipitation of the upper respiratory tract providing a similar picture to the
immune response findings”